Ultrasound Machine Cost: What Drives the Price from $850 to $6,900
From probe type to imaging depth, discover the hidden specs that separate a budget buy from a clinical-grade investment.
Ultrasound machine cost ranges from roughly $850 for a standalone therapeutic unit to nearly $6,900 for a fully modular combination system. The price gap reflects channel count, electrotherapy integration, frequency options, applicator variety, portability engineering, and platform expandability, each compounding on the others to justify structurally different hardware.
- The price spread reflects real differences in channel count, frequency options, electrotherapy integration, and whether the platform can grow with a practice over time.
- Standalone versus combination decision: A standalone unit makes sense if you already have capable electrotherapy equipment; a combination system earns its price premium only when those stim channels will actually see regular use.
- Four channels, three patients: Mid-range combination units with four independent stimulation channels let one practitioner treat up to three patients simultaneously, which meaningfully lowers per-treatment equipment cost in a busy clinic.
- Premium platforms justify their price with waveform depth and modular expandability, not just added channels, and those are only worth paying for if your protocols actually call for them.
- Five to seven year lifecycle: Modular systems cost more upfront but avoid replacement purchases when you add capabilities later, so plan total cost of ownership across a five to seven year horizon, not just the sticker price.
Where to start
Vectra Genisys 4-Channel Electrotherapy & Ultrasound Combination System with Cart
Chattanooga Intelect Transport 2 Electrotherapy & Ultrasound Combination System
What You Are Actually Paying For: The Core Cost Drivers
Therapeutic ultrasound machine cost spans a remarkably wide range, from just under $850 for a focused standalone unit to nearly $7,000 for a fully modular combination system. That gap is not arbitrary. It reflects genuine differences in clinical capability, channel count, frequency options, waveform libraries, and how much the device can expand as a practice grows.
Understanding what pushes a unit up the price ladder helps a clinician avoid both overspending on capability they will never use and underbuying on a unit that bottlenecks throughput. The major cost variables are: the number of stimulation channels, whether electrotherapy is integrated, the range of ultrasound frequencies and applicator sizes, onboard protocol libraries, portability engineering, and the modularity of the platform itself.
Each of those variables compounds. A four-channel device with a 12-waveform electrotherapy suite and three interchangeable applicator sizes is not just "more features," it is a structurally different piece of equipment that requires more sophisticated internal hardware, more rigorous calibration at manufacture, and typically a more extensive regulatory submission. The price difference is real, and it tracks.
Entry-Level Units: What $850 to $2,600 Gets You
At the lower end of the therapeutic ultrasound machine cost spectrum, you are looking at standalone or minimally integrated units with a tighter feature set. The Richmar SoundCare Plus, priced at $849.95, is a good reference point. It is a purpose-built therapeutic ultrasound system that ships with both 1 cm2 and 5 cm2 applicators in a dual-holster design, which is genuinely useful during treatment when you are switching between a small articular target and a broader soft-tissue area. The tradeoff is that there is no electrotherapy integration; it does ultrasound, and it does it well, but the clinical scope stops there.
The Richmar TheraTouch CX2 at $2,599.95 represents the next meaningful step. It adds two independent electrotherapy channels alongside 1 MHz and 3 MHz ultrasound, with both pulsed and continuous output modes available. The waveform library is substantial: Interferential, Premodulated, Biphasic variants, NMS, Russian, High Volt, and Microcurrent are all on board. There is also a bilingual English/Spanish interface and the ability to save up to 99 user-defined protocols. For a practice that sees a steady volume of musculoskeletal cases and needs both modalities without the overhead of a premium platform, this unit offers a lot of clinical range at a defensible price. A 5 cm2 ergonomic applicator with a maximum BNR ratio of 5:1 is included, though the cart is sold separately.
In this tier, the design philosophy prioritizes clinical essentials over expandability. You get reliable, calibrated delivery of the modalities on board, but you are not buying a system that grows with you. For a solo practitioner or a small clinic with well-defined treatment protocols, that is often exactly the right choice.
Mid-Range Combination Systems: $2,600 to $4,200
This is where the market becomes most competitive and where most outpatient and sports medicine clinics will land. The units here combine electrotherapy and ultrasound in meaningful ways, usually with more flexible channel configurations and better applicator options. The Richmar TheraTouch CX4, at $3,199.95, extends the CX2 platform to four independent stimulation channels and adds a multi-patient function that allows one practitioner to treat up to three patients simultaneously. For a busy practice, that capacity shift has a real effect on daily throughput and effectively lowers the per-treatment cost of the equipment over time.
The Chattanooga Intelect Transport 2 Combo at $4,173.48 takes a different approach to the same price tier. Its defining feature is portability: a built-in rechargeable battery pack and a quick-connect magnetic cart attachment let the unit move between a clinic table, a cart, and a sideline setting without tools. The ultrasound side offers 1 and 3.3 MHz frequencies with interchangeable applicators in 2 cm2, 5 cm2, and 10 cm2 sizes, each with an LED coupling indicator that removes the guesswork from transducer contact during treatment. The ability to store up to 15 custom protocols with independent controls for each stimulation channel adds meaningful workflow efficiency in a busy clinical environment.
Choosing between portability-focused and multi-channel-focused units at this price is largely a function of practice structure. A clinic that runs multiple simultaneous treatment bays benefits more from the CX4's channel count. A physio who splits time between a clinic and a sports facility will find the Transport 2's battery and magnetic mount far more valuable than a few extra channels they cannot always use on the road.
Premium and Modular Platforms: $5,000 and Above
At the upper end of the therapeutic ultrasound machine cost range, you are paying for two things that do not exist in the tiers below: waveform depth and platform modularity. The Chattanooga Intelect Legend 2 in its 2-channel configuration runs $5,108.35; the 4-channel version is $5,976.42. The Legend 2 platform includes 12 electrotherapy waveforms: VMS, Interferential, Pre-modulated, Symmetrical Biphasic, Asymmetrical Biphasic, HAN, Microcurrent, VMS Burst, Russian, Direct Current, High Volt, and VMS FR. Both 1 MHz and 3 MHz ultrasound frequencies are available independently or in combination with electrical stimulation. That combination mode, where ultrasound and electrotherapy are delivered simultaneously through the same applicator pathway, is a genuinely different clinical tool from sequential delivery and is one of the capabilities that justifies the price for practitioners who use it regularly.
The Vectra Genisys at $6,900.28 represents the ceiling of the product range and a different design philosophy entirely. Vectra describes it as the first modular therapy system to consolidate up to six therapeutic modalities in a single platform: ultrasound, electrotherapy, ultrasound/electrotherapy combination, laser, sEMG, and sEMG with stimulation. The modular architecture means a clinic can buy what they need now and add modules later without replacing the base unit. Applicators, including the included 5 cm2 ultrasound head, use Electronic Signature technology for automatic recognition, and all ultrasound and laser applicators are interchangeable. The ultrasound applicators also include a head-warming feature and are waterproof for underwater treatments, which matters in hydrotherapy and aquatic rehab contexts.
Buying at this tier is a fundamentally different financial calculation. You are not purchasing a device; you are purchasing a platform with a roadmap. If a clinic intends to add laser therapy or sEMG biofeedback in the next few years, buying the Vectra Genisys now and expanding it is likely cheaper than purchasing each capability as a separate unit later. The per-feature cost, amortized over a full platform build-out, tends to be lower than sequential single-purpose purchases.
Comparing the Models: Price, Channels, and Frequencies at a Glance
The table below summarizes the key differentiators across the main units in this category. Channel count and frequency range are the fastest indicators of where a unit sits clinically; price alone can mislead if two units at similar prices have meaningfully different configurations.
| Model | Channels | US Frequencies | Price |
|---|---|---|---|
 Richmar SoundCare Plus Professional Therapeutic Ultrasound System with 1 cm and 5 cm Applicators |
Ultrasound only | Not published | $849.95 |
 Richmar TheraTouch CX2 2-Channel Electrotherapy & Ultrasound Combination System |
2 | 1 MHz, 3 MHz | $2,599.95 |
 Chattanooga Intelect Transport 2 Therapeutic Ultrasound System |
Ultrasound only | 1 MHz, 3.3 MHz | $2,160.38 |
| Chattanooga Intelect Transport 2 Electrotherapy & Ultrasound Combination System |
2 | 1 MHz, 3.3 MHz | $4,173.48 |
 Chattanooga Intelect Legend 2 2-Channel Electrotherapy & Ultrasound Combination System |
2 | 1 MHz, 3 MHz | $5,108.35 |
 Chattanooga Intelect Legend 2 4-Channel Electrotherapy & Ultrasound Combination System |
4 | 1 MHz, 3 MHz | $5,976.42 |
A few patterns stand out. The standalone ultrasound units cluster below $2,200 and represent the most specialized, lowest-overhead option. Two-channel combo systems span an unusually wide range from about $2,600 to over $5,000, with the price difference driven primarily by portability engineering, waveform count, and brand platform investment. The four-channel units add meaningful per-session throughput capacity. For therapeutic ultrasound machines across this full range, the right entry point depends heavily on practice volume, patient mix, and whether you anticipate adding modalities in the next three to five years.
How Frequency Range and Applicator Options Affect Price
One of the less obvious cost drivers is applicator versatility. Units that ship with a single 5 cm2 applicator handle a broad range of soft-tissue targets adequately, but they cannot treat small joints, periarticular structures, or tight anatomical sites like the carpal tunnel or the posterior ankle with the same precision as a 1 cm2 head. The Richmar SoundCare Plus addresses this by including both a 1 cm2 and a 5 cm2 applicator in a dual-holster design, which is a real clinical advantage for a standalone unit at that price. The Chattanooga Transport line goes further, offering 2 cm2, 5 cm2, and 10 cm2 transmitters with LED coupling indicators, giving practitioners a wider targeting range and an objective confirmation of transducer contact quality during treatment.
Frequency selection between 1 MHz and 3 MHz (or 3.3 MHz in the Chattanooga units) is not a luxury feature; it is a clinical necessity for depth-differentiated treatment. Research on ultrasound penetration depth consistently shows that 1 MHz energy penetrates to deeper tissue layers, roughly 3 to 5 cm, while 3 MHz is attenuated more rapidly and is appropriate for superficial targets at 1 to 2 cm depth. A unit that only offers one frequency limits the practitioner to treating one tissue depth category. Systems with both options on board are more expensive to manufacture and calibrate, which is why dual-frequency capability tends to correlate with price tier, and why it is worth verifying before purchase rather than assuming.
The Vectra Genisys handles applicator management through its Electronic Signature system, where each head is automatically recognized by the unit on connection. This simplifies workflow but also reflects the engineering cost embedded in the platform. Waterproof applicators for underwater treatments, which the Genisys includes, require sealing and materials that add to unit cost while expanding the range of treatable conditions and treatment environments.
Combination Units versus Standalone: The Real Cost Tradeoff
The decision to buy a standalone ultrasound unit or a combination system is where a lot of practices either save money intelligently or make a regrettable compromise. A standalone unit is cheaper upfront and is the right call if a clinic already has a capable electrotherapy device and is simply adding or replacing ultrasound capability. Adding a $849.95 SoundCare Plus alongside existing stim equipment is a sensible, low-overhead decision. Buying a $2,600 combo unit to replace a standalone when the stim channels will rarely be used is not.
The argument for combination units gets stronger as practice volume grows. Research on musculoskeletal rehabilitation outcomes has documented that concurrent ultrasound and electrotherapy delivery, rather than sequential application, can improve treatment efficiency in conditions like adhesive capsulitis, bursitis, and chronic soft-tissue injuries. Whether that translates to a measurable clinical advantage in a given setting depends on the conditions being treated, but for a practice that already uses both modalities regularly, a well-integrated combo system reduces setup time, reduces cable management, and frees up table space. Those are practical gains that accrue across hundreds of patient sessions.
The question of whether your practice genuinely needs both modalities is worth answering before the purchase, not after. Whether ultrasound and electrotherapy serve the same patient population in a given clinic is not always obvious, and the answer has a direct bearing on whether a combination unit at twice the price of a standalone is justified.
Protocol Libraries, Interfaces, and Their Workflow Value
Clinical protocol libraries are a feature that sounds like a convenience but functions more like a risk management tool. An interface that surfaces evidence-based electrode placement recommendations and validated starting parameters reduces variability between practitioners treating the same indication and reduces the likelihood of parameter errors during a busy session. The Richmar TheraTouch CX2 includes eight evidence-based stimulation protocols and saves up to 99 user-defined ones. That capacity for customization means a practice can build its own library of condition-specific protocols over time, which is particularly valuable in sports medicine or high-volume rehab settings where practitioners want repeatable, defensible treatment records.
The Chattanooga Intelect Transport 2 offers up to 15 custom memory positions with independent controls for each stim channel. That is a more limited library by number, but the portability of the unit means those 15 protocols may represent a field-optimized subset rather than a complete protocol database. The tradeoff is intentional: a sideline or home-visit device needs fast access to the most commonly used settings, not a comprehensive library that takes time to navigate. Understanding how protocols are structured on a given unit, and whether the menu system is genuinely fast to use under clinical pressure, is worth asking about before committing to a platform.
Touchscreen interfaces with menu-driven navigation have largely replaced analog dial systems in this price range, and for good reason. The ability to review parameters on-screen before delivery, confirm output mode, and adjust pulse duration mid-treatment without lifting the applicator improves both safety and workflow. The LCD touch interface on the Richmar TheraTouch line is consistently cited as a practical strength, and the bilingual capability (English and Spanish) is worth noting for clinics serving multilingual patient populations.
Long-Term Cost: Why Modularity Changes the Calculation
The Vectra Genisys's modular design deserves more attention than a simple price comparison suggests. At $6,900.28 for the base configuration, it is the most expensive unit in this range. But the modular architecture means that adding laser therapy, sEMG, or combination delivery later does not require purchasing a new device. A clinic that starts with the ultrasound and electrotherapy configuration and adds laser two years later is paying for expansion, not replacement. That distinction matters when calculating total cost of ownership over a five to seven year equipment lifecycle, which is the horizon most clinics should be planning against.
Fixed-platform units, by contrast, are exactly what they ship as. The Chattanooga Intelect Legend 2 is an excellent clinical device with a deep waveform library and reliable dual-frequency ultrasound, but if a practice later decides it needs sEMG capability, that requires a separate purchase. Neither approach is wrong; they suit different planning horizons and growth trajectories. A practice with a stable, well-defined treatment menu is likely better served by a fully specified fixed-platform unit. A practice that is actively expanding its modality offerings should think hard about whether a modular platform reduces long-term capital expenditure.
There is also a maintenance and calibration angle worth considering. Modular systems with interchangeable applicators and automatic electronic recognition require less manual configuration between uses, but they do introduce more connection points that can wear over time. Fixed applicator systems have fewer mechanical failure points. Neither concern should dominate the purchase decision, but both are worth factoring into a realistic assessment of ownership cost beyond the sticker price.
Matching Budget to Clinical Need: A Practical Framework
A few questions narrow the field quickly. First: does the practice currently use electrotherapy at all? If yes, a combination unit is probably the right starting point. If not, a standalone unit at a lower price point lets a practice add ultrasound capability without committing to a combined workflow they may not adopt. Second: how many patients are treated per day, and how many could realistically receive ultrasound or stim in a session? A four-channel system only justifies its price premium over a two-channel one if the additional channels are genuinely in use. Third: is the unit stationary or does it need to travel? Portability engineering is expensive, and paying for it when a unit never leaves the clinic room is unnecessary.
Once those three questions are answered, the comparison table above narrows to two or three candidates. At that point, the decision usually comes down to protocol depth, applicator options, and whether the platform is expandable. For clinics where the modality choice between a standalone and a combination unit is still open, working through the clinical use cases before pricing is the more efficient sequence.
It is also worth considering what the research says about therapeutic ultrasound efficacy more broadly. The evidence base for therapeutic ultrasound in soft-tissue conditions, including tendinopathy, adhesive capsulitis, and chronic musculoskeletal pain, is well established, though effect sizes vary considerably by condition, parameter selection, and delivery technique. Investing in a unit that offers precise frequency selection, calibrated output, and a reliable BNR figure gives a practitioner more control over the variables that the literature consistently identifies as influential. A cheaper unit that omits those controls is not a neutral financial decision; it is a clinical tradeoff.
For practitioners who want a broader view of the evidence before committing to a unit, the documented physiological effects of therapeutic ultrasound across different conditions provide a useful lens for evaluating which device capabilities actually translate to clinical outcomes. The goal of the purchase is not the device itself but the treatment range it enables, and grounding that in the research is the most defensible starting point for a significant capital expenditure.
More therapeutic ultrasound machines worth a look
Richmar TheraTouch CX4 4-Channel Electrotherapy & Ultrasound Combination System
Richmar TheraTouch CX2 2-Channel Electrotherapy & Ultrasound Combination System
Frequently asked questions
What is the typical cost range for a therapeutic ultrasound machine?▾
Therapeutic ultrasound machines sold for clinical use range from just under $850 for a standalone unit up to nearly $6,900 for a fully modular combination system. The Richmar SoundCare Plus sits at the entry point at $849.95, while the Vectra Genisys 4-Channel system reaches $6,900.28. Where a unit falls in that range depends on channel count, electrotherapy integration, frequency options, and whether the platform is designed to expand.
Is a therapeutic ultrasound machine suitable for a small or solo practice?▾
A two-channel combination unit like the Richmar TheraTouch CX2 at $2,599.95 covers most of what a solo practitioner needs: 1 MHz and 3 MHz ultrasound, eight electrotherapy waveforms including Interferential and Russian, and up to 99 saveable protocols. If your caseload is primarily musculoskeletal and you have predictable treatment protocols, a mid-range unit will rarely leave you short. The main limitation is that single-practitioner units are not built for simultaneous multi-patient use.
What safety specification should I check before buying any ultrasound machine?▾
Pay attention to the BNR, or Beam Non-Uniformity Ratio. A lower BNR means the energy is distributed more evenly across the transducer face, which reduces the risk of hot spots forming in tissue during treatment. The FDA generally treats 5:1 as the acceptable ceiling for therapeutic use, and the Richmar TheraTouch CX2 publishes a maximum BNR of exactly 5:1 with its included 5 cm2 applicator. Any unit that does not publish this figure is worth questioning before purchase.
How much does a clinical-grade combination electrotherapy and ultrasound system cost?▾
Most combination systems fall between $2,600 and just over $6,900. The Richmar TheraTouch CX2 starts the category at $2,599.95 with two channels and a solid waveform library. The Chattanooga Intelect Transport 2 sits at $4,173.48 and adds portability through a built-in rechargeable battery and magnetic cart mount. At the top, the Vectra Genisys at $6,900.28 supports up to six modalities in a single modular platform.
What does setup involve for a therapeutic ultrasound machine?▾
Most units arrive ready to use with their included applicator, though some, like the Richmar TheraTouch CX2, are unit-only with the cart sold separately, so factor that into your room layout planning. Systems like the Chattanooga Intelect Transport 2 attach to a cart via a quick-connect magnetic mount, which makes positioning straightforward without tools. Applicator recognition on the Vectra Genisys is handled electronically, so swapping heads is as simple as plugging in the correct transducer.
What are the ongoing costs of running a therapeutic ultrasound machine?▾
Ultrasound gel is the main consumable, used with every treatment session to ensure proper transducer coupling. Beyond that, applicator heads can wear over time, particularly if used frequently in underwater treatment settings, though units like the Vectra Genisys feature waterproof applicators that hold up better in those conditions. Calibration checks are good practice and may be required depending on your jurisdiction, but the manufacturer does not publish a set service interval for the units in this range.
How do I choose the right size applicator for my patients?▾
Applicator size should match the treatment area. A 1 cm2 head works well for small, targeted structures like finger joints or the AC joint, while a 5 cm2 head suits most soft-tissue and mid-sized joint treatments. The Chattanooga Intelect Transport 2 goes further, offering interchangeable transmitters in 2 cm2, 5 cm2, and 10 cm2 sizes, the 10 cm2 being practical for larger muscle groups like the quadriceps or lumbar paraspinals. Having options matters clinically, because using a large applicator on a small target dilutes the effective dose.
What is the most common mistake clinicians make when buying an ultrasound machine?▾
Buying on channel count alone without thinking about how the practice actually runs. A four-channel unit like the Richmar TheraTouch CX4 at $3,199.95 lets one practitioner treat up to three patients at once, which is genuinely useful in a busy outpatient setting. But a solo practitioner who rarely runs parallel treatments will not extract that value and may be better served by investing in portability, such as the Chattanooga Intelect Transport 2, or a broader frequency range rather than extra channels that sit idle.
Shop therapeutic ultrasound machines
Quality inspected before shipping, with expert US-based phone support before and after purchase.
